Reference list

    1. Bays RA, Hamerlinck F, Cormane RH, Immunoglobulin bearing lymphocytes and polymorphonuclear leucocytes in recurrent aphtous ulcers in man. Arch Biol 1977; 22: 147
    2. Boer OJ, Loos CM van der, Hamerlinck F, Bos JD, Das PK, Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. Arch Dermatol Res 1994; 286: 87-96.
    3. Bos JD, Hamerlinck F, Cormane RH, Antitreponemal IgE in early syphilis. Br J Venereal Dis 1980; 56: 20-25.
    4. Bos JD, Hamerlinck F, Cormane RH, Immunoglobulin-bearing lymphoid cells in primary syphylis, Br J Venereal Dis 1980; 56:69-73.
    5. Bos JD, Hamerlinck F, Cormane RH, T-lymphoid cells in primary syphilis. Br J Venereal Dis 1980; 56: 74-76.
    6. Bos JD, Hamerlinck F, Interaction of syphilitic sera and normal T-lymphoid cells. In: Bos JD. Ed. Immunological aspects of syphilis. Thesis 1981.
    7. Buhrer – Sekula S, Hamerlinck F, Out TA, Bordewijk LG, Klatser PR, Simple Dipstick assay for semi-quantitative detection of neopterin in sera. J. Immun. Methods 2000; 238: 55-58.
    8. Cormane RH, Husz S, Hamerlinck F, Immunoglobulin and complement bearing lymphocytes in eczema. Br J Dermatol 1973; 88: 307.
    9. Cormane RH, Husz S, Hamerlinck F, Immunoglobulin and complement bearing Lymphocytes in contact dermatitis and atopic dermatitis. Br J Dermatol 1974; 90: 597.
    10. Cormane RH, Hamerlinck F, Husz S, Elution of Antibodies from the lymphocyte membrane in certain dermatoses. Br J Dermatol 1974; 91: 315.
    11. Cormane RH, Husz S, Hamerlinck F, Valk MAT van der, Le rôle et le rapport de lymphocytes B et T dans certaines variétés d’eczéma. Ann Dermatol et Syph. 1974; 101: 382.
    12. Cormane RH, Hamerlinck F, Husz S, B and T lymphocytes in certain varieties of dermatitis, Annals New York Acad of Sciences 1975; 254: 592.
    13. Cormane RH, Hunyadi J, Hamerlinck F, Polymorphonuclear leucocytes bearing immunoglobulins and complement in allergic conyact dematitis and psoriasis. J Invest Dermatol 1975; 64: 289.
    14. Cormane RH, Hunyadi J, Hamerlinck F. Mécanismes immunologiques du psoriasis. Ann Dermatol et Syph. 1976: Suppl. 1:64.
    15. Cormane RH, Hamerlink F. Husz S, B und T Zellen bei verschiedene Formen von Dermatitis. Der Hautartzt 1976; Suppl. 1; 64.
    16. Cormane HR, Hunyadi J, Hamerlinck F, The role of Lymphoid cells and polymorphonuclear leucocytes in the pathogenesis of psoriasis. J Dermatol 1976; 3: 247.
    17. Cormane RH, Hunyadi J, Hamerlinck F, Photoimmunology in Psoriasis. Paper presented in the second Symposium in Psoriasis, Stanford USA. 1976.
    18. Cormane RH, Hamerlinck F, Simon M, Siddiqui AH, Photoimmunology in Psoriasis. J Invest Dermatol 1977; 68: 253.
    19. Cormane RH, Hunyadi J, Hamerlinck F, immunogenetische Aspekte der Pathogenese der Psoriasis, Derma. Monatschr. 1977; 163: 885-889.
    20. Cormane RH, Hamerlinck F, Simon M, Siddiqui AH, Photoimmunology in Psoriasis.Paper presented at the Dermatological Conference et Cairo, Egypt. Organized by Memphis Chemical Co.,Memphis, Egypt. 1977.
    21. Cormane RH, Hamerlinck F, Simon M, Siddiqui AH, Immunological aspects of therapy with oral 8-MOP and UVA in healthy controls and psoriasis patients. Photochemotherapy. Ed. by Philips Nederland BV, Eindhoven, The Netherlands.1978.
    22. Cormane RH, Hamerlinck F, Nunzi E, Antibodies eluted from Lymphoid cell membrane. Occurence in certain varieties of Scleroderma. Arch Dermatol 1979; 115: 709.
    23. Cormane RH, Hamerlinck F, Nunzi E, Antibodies against endothelia. In Wolff K. ed. Proceedind of the International Symposium on Vasculitis, 1979.
    24. Cormane RH, Hamerlinck F, Nunzi E, Antibodies eluted from lymphoid cell membrane. Arch Dermatol 1979; 115: 709-712.
    25. Cormane RH, Hamerlinck F, Nunzi E, Elution d’anticorps de la membrane des Lymphocytes dans certains variétés de sclerodermie. Immunophatologie cutanée. 79; 80: 133.
    26. Cormane Rh, Nunzi E, Hamerlinck F, Antibodies in Alopecia Areata. Paper presented at the first Internal Congress of Hair Research. Hamburg, Germany 1979.
    27. Cormane RH, Hamerlinck F, Siddiqui AH, Immunologic implications of Puva Therapy. Arch of Dermatol Res. 1979; 265: 245-267.
    28. Hamerlinck F. Neopterin: a review. Exp. Dermatol 1999; 8: 167-176.
    29. Hamerlinck F, Faber WR, Borderwijk L, Bos JD, Serum Neopterin levels in patiënts with different forms of leprosy. Paper presented at the Symposium on Leprosy Research. Santa Margherita, Italy 1990.
    30. Hamerlinck F, Hermans MHE, Westerhof W, The treatment of biopsy-donorsites and autografted acceptorsites with duoderm and unitulle: a comparative study in patiënts with leg ulcers. Phlebologie 89, Strasbourg, sept. 1989 10éme Congres Mondial Union Internationale de Phlebologie. 1989; 1193-1195.
    31. Hamerlinck F, Boyden B, Oei HD, Niordson AM, Avrach W, Ottenvanger V, Danzig MR, A comparison of loratadine and astemizole in the treatment of chronic idiopathic urticaria. Poster, presented at 2nd Congress of the European Academy of Dermatology and Venereology. Athens, Greece 1991.
    32. Hamerlinck F, Faber WR, Klatser PR, Bos JD, Neopterin as a marker for reactional leprosy. Experimental Dermatol, 1992; 1, nr2: 101.
    33. Hamerlinck F, Faber WR, Klatser PR, Bos JD, Neopterin as a marker for reactional leprosy. Paper presented at the 5th Immunodermatology Symposium. Szeged, Hungary 1992.
    34. Hamerlinck F, Faber WR, Klatser PR, Bos JD, Neopterin as a marker for reactional leprosy. Paper presented at the 14th international Leprosy Congress, Orlando, Florida USA 1993.
    35. Hamerlinck F, Boyden B, Oei HD, Niordson AM, Avrach W. Ottevanger V, Danzig MR, A Double-blind comparative study of loratadine and astemizole in chronic idiopathic urticaria. J Dermatol Treatment 1994; 5: 199-202.
    36. Hamerlinck F, Schimmelinfecties bij de gepigmenteerde huid, Tijdschrift voor Huisarts Geneeskunde 14, nr.5: 26-30. 1996.
    37. Hamerlinck F. Wal van der A, Laane HM, Efflorescenties van de gepigmenteerde huid, Glaxo 1998.
    38. Hamerlinck F, Toonstra J, Vloten van WA, Increased serum neopterin levels in Mycosis Fungoides and Sézary syndrome, Br J Derm 2000.
    39. Hamerlinck F, Klatser PR, Walsh DS, Bos JD, Walsh GP and Faber WR, Serum neopterin as a marker for reactional states in Leprosy. FEMS Immun Med Microbiol 1999; 24: 405-409.
    40. Hamerlinck F, Albert C, Serum neopterin in Sarcoidosis; an additional nonspeciffic marker of disease activity. Chapter 5 Thesis 1999.
    41. Hamerlinck F, Gool van T, Faber WR and Kager P, Serum neopterin concentrations during treatment of leishmaniasis: useful as test of Cure? Fems Immunol Med Microbiol 2000; 27: 31-34.
    42. Hamerlinck F, Steenkamer Th. A. Etnische dermatologie voor de eerste lijn. 2010 DCHG, Medische communicatie.
    43. Hunyadi J, Hamerlinck F, Cormane RH, Immunoglobulin and complement bearing polymorphonuclear leucocytes in allergic contact dermatitis and psoriasis vulgaris. BR. J Dermatol 1976; 94: 417.
    44. Husz S, Hamerlinck F, Cormane RH, Prealbumin bearing lymphocytes as an indicator of hapten protein carrier in certain varieties of dermatitis. Br J Dermatol 1975; 93: 11.
    45. Nunzi E, Rebora A, Hamerlinck F. Cormane RH, Immunopathological studies on rosacea. Br J Dermatol 1980; 103: 543.
    46. Polderman MCA, Hamerlinck F, Pavel S, De schaduwzijde van het zonlicht Huidkanker, 3, nr11: 36-40. 1996.
    47. Rie MA de, Hamerlinck F, Bos JD, Neopterin, immune activation and psoriasis. The Lancet 1991; 338: 1208.
    48. Rie MA de, Hamerlinck F, Hintzen RQ, Bos JD, Lier RAW van, Quantitation of soluble CD27 a T-cell activation antigen, and soluble interleukin-2 –receptor in serum from patiënts with psoriasis, Arch Dermatol Res 1991; 283: 533-534.